{"chebi_id":"6438","chebi_name":"levobunolol","chebi_synonyms":["(-)-Bunolol","levobunololum","5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one","Levobunolol","(S)-5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone"],"diffprof_id_observed":["MTBLS2145_0002_00000029"],"diffprof_id_var_observed":["MTBLS2145_0002_00000029"],"inchikey":"IXHBTMCLRNMKHZ-LBPRGKRZSA-N","inn_name":"levobunololum","iupac_name":"5-[(2<i>S</i>)-3-(<em>tert</em>-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2<em>H</em>)-one","num_study_observed":1,"reactome_ids":["R-HSA-162582","R-HSA-372790","R-HSA-373076","R-HSA-375280","R-HSA-390696","R-HSA-500792"],"reactome_names":["Signal Transduction","Signaling by GPCR","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Adrenoceptors","GPCR ligand binding"],"study_id_observed":["MTBLS2145"],"study_id_var_observed":["MTBLS2145"],"synonym_name":"(-)-Bunolol"}